SCHEMBL13338397

SCHEMBL13338397

CC(C)N(c1ccccc1)c1cccc(C(F)(F)F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.44
▸ TDO2 P48775 1/20 0.44
▸ HTR2A P28223 1/20 0.44
▸ HTR2C P28335 1/20 0.44
▸ HTR2B P41595 1/20 0.44
▸ TSHR P16473 3/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ TACR1 P25103 2/20 0.43
▸ RORC P51449 1/20 0.43
▸ ACP3 P15309 1/20 0.43
▸ CETP P11597 2/20 0.43
▸ NR1H3 Q13133 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13338543 0.84 ALDH1A1 (0.48) TSHRALDH1A1TACR1ACP3MAPK1
SCHEMBL14040002 0.81 RORC (0.46) HTR2AHTR2CHTR2BRORCACP3
SCHEMBL10599602 0.80 MEN1 (0.45) ALDH1A1TACR1ACP3NPSR1MEN1
SCHEMBL18387854 0.80 HTR2A (0.47) HTR2AHTR2CHTR2BTSHRRORC
SCHEMBL13338731 0.79 CETP (0.43) HTR2AHTR2CHTR2BCETPMEN1
SCHEMBL15013852 0.79 HTR2A (0.46) HTR2AHTR2CHTR2BTSHRALDH1A1
SCHEMBL25917007 0.78 HDAC8 (0.40) ALDH1A1RORCNR1H3MAPK1MEN1
Isopropyldiphenylamine SCHEMBL27697074 0.77 ALDH1A1 (0.50) HTR2AALDH1A1NPSR1MEN1KMT2A
Isopropyldiphenylamine SCHEMBL2119054 0.77 ALDH1A1 (0.50) HTR2AALDH1A1NPSR1MEN1KMT2A
Isopropyldiphenylamine SCHEMBL2119060 0.77 ALDH1A1 (0.50) HTR2AALDH1A1NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 IDO1 2425/4885TDO2 1844/4885HTR2A 2417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback